BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 15, 2026
Home » Authors » Nuala Moran

Articles by Nuala Moran

Curnock Cook Investing Again After Forming New €150M Fund

April 30, 2003
By Nuala Moran
No Abstract
Read More

PPL Gives Up Plans On Plant To Manufacture AAT Product

April 30, 2003
By Nuala Moran

Alizyme Eyes Phase III, Alliance Following Renzapride Results

April 30, 2003
By Nuala Moran

Progress In Two Early Programs Gives Xenova Much-Needed Lift

April 23, 2003
By Nuala Moran

Celltech Brings On New CEO Following Purchase Of OGS

April 23, 2003
By Nuala Moran
LONDON - It was all change last week as members of the Oxford GlycoSciences plc board resigned to make way for directors from its new owner, Celltech Group plc, and Celltech announced the appointment of its new CEO, Goran Ando. (BioWorld International)
Read More

CeNeS Sells Three Products To Strengthen Cash Position

April 23, 2003
By Nuala Moran

Oxford BioMedica Cuts Back On Programs To Extend Cash

April 23, 2003
By Nuala Moran

Celltech Brings On New CEO Following Purchase Of OGS

April 23, 2003
By Nuala Moran
LONDON - It was all change last week as members of the Oxford GlycoSciences plc board resigned to make way for directors from its new owner, Celltech Group plc, and Celltech announced the appointment of its new CEO, Goran Ando. (BioWorld International)
Read More

CeNeS Sells Three Products To Strengthen Cash Position

April 23, 2003
By Nuala Moran

Oxford BioMedica Cuts Back On Programs To Extend Cash

April 23, 2003
By Nuala Moran
Previous 1 2 … 485 486 487 488 489 490 491 492 493 … 540 541 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • 3D illustration of a nerve cell

    Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

    BioWorld
    Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
  • Illustration of Lactobacillus

    Microbiota modulates the antidepressant effects of GLP-1 analogues

    BioWorld Science
    Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing